Is Procept Biorobotics Corp. (PRCT) the Worst AI Stock to Buy?
Procept Biorobotics Corporation (PRCT): Why Are Short Sellers Betting Against This Hospital Tech Innovator?
Form 144 | PROCEPT BioRobotics(PRCT.US) Insider Proposes to Sell 4.06 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Sep 16, $PROCEPT BioRobotics(PRCT.US)$ Insider Kevin Waters intends to sell 50,000 shares of its common stock on Sep 16, with a total market value of approximately $4.06
PROCEPT BioRobotics Currently Up Nine Consecutive Days, Longest Winning Streak Since September 2023 -- Data Talk
PROCEPT BioRobotics Is Maintained at Buy by TD Cowen
PROCEPT BioRobotics Analyst Ratings
TD Cowen Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Raises Target Price to $99
Buy Rating Affirmed for PROCEPT BioRobotics on Hydros Platform Launch and Positive Long-Term Growth Outlook
Is PROCEPT BioRobotics (NASDAQ:PRCT) Using Too Much Debt?
PROCEPT BioRobotics(PRCT.US) Director Sells US$9.38 Million in Common Stock
Northside Hospital Forsyth and Georgia Urology First in World to Offer Next-Generation, AI-Powered Treatment of Enlarged Prostate
PROCEPT BioRobotics(PRCT.US) Director Sells US$7.74 Million in Common Stock
Form 144 | PROCEPT BioRobotics(PRCT.US) Director Proposes to Sell 12.73 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Sep 4, $PROCEPT BioRobotics(PRCT.US)$ Director 222 DNA TRUST intends to sell 169.58K shares of its common stock on Sep 4, with a total market value of approximately $12.73
Jim Cramer Says This Retailer Yields 3%: 'Which Is Quite Good'
Truist Financial Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Maintains Target Price $95
Form 144 | PROCEPT BioRobotics(PRCT.US) Director Proposes to Sell 4.16 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Sep 3, $PROCEPT BioRobotics(PRCT.US)$ Director ANTAL ROHIT DESAI intends to sell 52,640 shares of its common stock on Sep 3, with a total market value of approximately $4.16
Truist Financial Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Announces Target Price $95
Express News | Procept Biorobotics Corp : Truist Securities Raises Target Price to $95 From $74
Do You Believe in the Growth Prospects of PROCEPT BioRobotics (PRCT)?
PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024